Dr. Michael Blundell

Product Manager, Bio-Rad Laboratories

Dr. Michael Blundell completed an undergraduate degree in immunology at the University of Edinburgh before joining the group of Professor Adrian Thrasher at University College London. His PhD thesis focused on the primary immunodeficiency, Wiskott Aldrich Syndrome. He investigated novel activating mutants and developed retroviral and lentiviral vectors, which have now been successfully used in clinical trials. After almost 20 years in academia, he decided to take another turn in his career and joined Bio-Rad in 2015. As a global product manager for flow cytometry, he uses his application and scientific knowledge to develop new reagents, fulfilling the needs of flow cytometry users.

New Tools for Drug Discovery: Advances in Flow Cytometry

Improvements in cytometer technology as well as the increased access to suitable dyes with desirable characteristics have been critical factors in improving the utility of flow cytometry as a drug discovery platform.